← Research Library
Arthritis1 min read

Therapeutic effects of Melittin acupoint injection on rheumatoid arthritis through autophagy activation and PI3K/AKT/mTOR pathway inhibition.

Quantitative imaging in medicine and surgery·January 2026·Weizhe Xi, Fenfang Liu, Guangen Zhong et al.
Share:PostShare

Key Finding

Melittin acupoint injection significantly reduced rheumatoid arthritis symptoms and joint damage by inhibiting the PI3K/AKT/mTOR pathway and promoting cellular autophagy in a mouse model.

What This Means For You

Researchers investigated whether melittin acupoint injection (MAI), a traditional Chinese medicine treatment using bee venom components delivered at acupuncture points, could help manage rheumatoid arthritis (RA). RA is a chronic autoimmune condition causing joint inflammation, cartilage damage, and bone destruction that significantly impacts quality of life.

The study used mice with induced arthritis, dividing them into groups receiving MAI through subcutaneous or intramuscular injection at acupoints, standard medication (methotrexate), or no treatment. All treatments continued for 28 days. Researchers measured joint swelling, arthritis severity, inflammation markers, and examined joint tissue and bone changes.

MAI significantly reduced joint swelling, arthritis scores, and paw thickness compared to untreated arthritic mice. Microscopic examination showed less inflammatory cell infiltration, reduced synovial tissue overgrowth, and decreased cartilage damage. Imaging revealed less bone destruction and cartilage erosion. Blood tests showed MAI lowered inflammatory markers (TNF-α, IL-1β, IL-17A) while increasing anti-inflammatory IL-10. The researchers discovered MAI works by blocking the PI3K/AKT/mTOR pathway and activating autophagy, a cellular cleaning process that removes damaged components.

These findings suggest acupoint injection therapy with melittin may offer a promising treatment approach for RA by reducing inflammation and joint damage through specific molecular mechanisms. The treatment appeared comparable to standard medication in several measures. While this animal study shows encouraging results, human clinical trials are needed to confirm effectiveness and optimal dosing protocols.

If you're considering acupuncture or related therapies for rheumatoid arthritis, consult with a licensed acupuncturist or integrative medicine practitioner experienced in treating autoimmune conditions.

Clinical Notes for Practitioners

This preclinical study examined melittin acupoint injection (MAI) efficacy in collagen-induced arthritis (CIA) mice over 28 days. Forty mice were divided into five groups (n=8): normal control, CIA model, subcutaneous MAI (ST), intramuscular MAI (IT), and methotrexate control. Outcomes included arthritis index, joint swelling, micro-CT imaging, histopathology, and serum cytokine analysis.

MAI significantly reduced plantar thickness, AI scores, and swollen joints (P<0.05). Histopathological analysis demonstrated decreased inflammatory infiltration, synovial proliferation, and cartilage damage (P<0.01). Micro-CT confirmed reduced bone destruction. Serum analysis showed decreased IL-1β (P<0.05), IL-17A, and TNF-α (P<0.01), with increased IL-10 (P<0.05). Western blot revealed elevated autophagy markers (ULK1, beclin-1, LC3II; P<0.01-0.05) and reduced PI3K/AKT/mTOR phosphorylation (P<0.05).

Clinical implications: MAI demonstrates anti-inflammatory effects through autophagy activation and PI3K/AKT/mTOR pathway inhibition. Results suggest acupoint injection therapy warrants investigation as an adjunctive RA treatment, though human trials are needed to establish clinical protocols.

Found this research helpful?

Share:PostShare
🌿

Ready to try acupuncture for Arthritis?

Browse our directory of verified licensed practitioners near you.

Find a practitioner →

Related researchin Arthritis